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1. Introduction 
Several years ago, results from our laboratory 
demonstrated [I] that partially delipidized very low 
density lipoproteins (VLDL, d < 1.006 g/ml) isolated 
from hypertriglyceridemic plasma contained 3 separ- 
able phospholipid-protein residues; the protein 
moieties of two of these were identical to apolipo- 
proteins A and B (ApoA and ApoB). The protein 
moiety of the third residue was characterized by a 
high capacity for phospholipid binding, immunological 
properties and peptide patterns different from those 
of ApoA and ApoB, and by serine and threonine as 
N-terminal amino acids. This newly recognized pro- 
tein-moiety, designated as apolipoprotein C (ApoC), 
was also found in the chyle VLDL [2] and in all the 
major density lipoprotein classes isolated from normal, 
fakting human plasma [3] . Recently, Brown et al. [4] 
confirmed the presence in VLDL of 3 phospholipid- 
protein residues, one of which gave a specific immuno- 
precipitin reaction only with antibodies to VLDL. In 
addition, these authors separated the soluble protein 
moiety of totally delipidized VLDL by gel filtration 
into 2 major fractions. One fraction consisted of ApoA 
polypeptides, whereas the second contained a mixture 
of polypeptides characterized by serine and threonine 
as N-terminal amino acids. Chromatography of this 
fraction on a DEAE-cellulose column resulted in the 
isolation of 3 polypeptides which were designated on 
the basis of their C-terminal amino acids as apoLP-Val 
(“R-V$‘), apoLP-Glu (“R-Glu”), and apoLP-Ala 
(“R-Ala”) [5, 61 . To investigate the possible relation- 
ship between ApoC and polypeptides “R-Val”, 
North-Holland Publishing Company - Amsterdam 
“R-Glu” and “R-Ala”, we have isolated ApoC from 
VLDL by immunoprecipitation [7] and established 
[3,8] that it consists of 3 immunologically distinct 
polypeptides which correspond in almost all chemical 
properties to those isolated by Brown et al. Since all 3 
polypeptides seem to be required for the formation 
of a high density lipoprotein C (LP-C) [9] and an 
abnormal low density lipoprotein (LP-X) in obstruc- 
tive jaundice [lo] , we have suggested that ApoC 
consists of three non-identical polypeptides designated 
as C-I (“RVal”), C-II (“R-Glu”) and C-III (“R-Ala”). 
In the course of our studies on the characterization 
of ApoC-polypeptides, we could not confirm valine as 
the C-terminal amino acid of C-I (“R-Val”). This 
report presents evidence that C-I polypeptide is 
characterized by serine as the C-terminal and threo- 
nine as the N-terminal amino acid. 
The significance of this finding is discussed with 
respect to its possible influence on and significance 
for a new nomenclature of plasma lipoproteins. 
2. Experimental procedure 
2.1. Isolation of human plasma VLDL 
VLDL were isolated from pooled human plasma 
by preparative ultracentrifugation at 105,000 g for 22 
hr in the Ti60 rotor at plasma density. The top layer 
was removed by tube slicing, diluted with 0.15 M 
NaCl, and recentrifuged 2 times under the original 
isolation conditions. The VLDL, free of albumin as. 
determined by double diffusion, was then dialyzed 
against distilled water and lyophilized. 
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2.2. Isolation of C-I polypeptide 
Delipidization of the lyophilized VLDL was 
accomplished by 6 successive xtractions with 
ethanol-diethyl ether (3: 1, v/v) at 4” including one 
overnight extraction. This was followed by 3 extrac- 
tions with diethyl ether. Totally delipidized VLDL 
(apoVLDL) were partially soluble in 0.1 M 
(NH,),CO, at pH 9.0 and the soluble portion was 
lyophilized and fractionated by a modified procedure 
of Brown et al. [4] . The soluble apoVLDL was 
chromatographed on Sephadex G-100 column 
(2.5 X 100 cm) equilibrated with 0.1 M (NH,),COs . 
Of the 2 major fractions collected, the first one con- 
sisted of ApoA and the second of ApoC polypeptides. 
The lyophilized ApoC fraction was applied to a DEAE- 
cellulose column (30 X 1.5 cm) prepared as described 
previously [ 111. Elution with a linear gradient from 
0.005 to 0.10 M NaCl containing 8 M urea at pH 7.2 
yielded 4 major peaks. The first peak which contained 
C-I polypeptide was dialyzed against distilled water, 
lyophilized and utilized for subsequent investigation. 
2.3. Analytical and immunochemical methods 
The polypeptide was examined by double diffusion 
and immunoelectrophoresis in 1% agar according to 
previously described procedures [lo] . Rabbit antisera 
to human LP-A, LP-B and LP-C were prepared as 
previously described [ 121. Rabbit antibodies to human 
IgG, IgA, IgM, whole serum, and albumin were pur- 
chased from Behringwerke AG, Marburg an der Lahn, 
Germany. 
N-terminal amino acids were determined with 
dansyl-chloride and carboxy-terminal amino acids by 
hydrazinolysis and carboxypeptidase A and B using 
procedures previously described [lo] . Amino acid 
analyses were performed on a Beckman Model 120C 
analyzer by an accelerated procedure on spherical 
resins [ 121 , 
3. Results and discussion 
3.1. Characterization of the C-Zpolypeptide 
Double diffusion analysis of C-I revealed a single 
precipitin line with antibodies to LP-C and no reaction 
with antibodies to LP-A, LP-B, IgG, IgA, IgM, albumin 
or whole serum. On agar immunoelectrophoresis, the 
C-I polypeptide displayed a characteristic migration 
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Fig. 1. Immunoelectrophoresis of C-I polypeptide on 1% agar. 
Trough contains antibodies to LPC. 
towards the cathode and gave a precipitin arc only 
with antibodies to LPC (fig. 1). Amino acid analysis 
of C-I demonstrated the absence of tyrosine, histidine, 
cystine, and cysteine. From these results and the 
elution patterns on Sephadex G-100 and DEAE-cellu- 
lose columns, it was concluded that the C-I polypep- 
tide corresponded to the “R-Val” polypeptide 
described by Brown et al. [4,6]. 
3.2. C-terminal amino acid 
Brown et al. [4] reported that digestion of C-I 
polypeptide (“R-Val”) with carboxypeptidase A or B 
at 27” resulted in no release of amino acids. However, 
on the basis of a hydrazinolysis experiment, they con- 
cluded that this polypeptide contains valine as the 
C-terminal amino acid and suggested that it be called 
“R-Val” or apoLP-Val. Failure to confirm this result 
in routine characterization analyses of C-l polypeptide 
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Fig. 2. Release of amino acids from C-I polypeptide with 
carboxypeptidases A and B at pH 5.8 and 37”. The ratio of 
enzymes to polypeptide was 1:80. 
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Fig. 3. Release of ammoSacids from C-I polypeptide with 
carboxypeptidases A and B at pH 8.5 and 37”. The ratio of 
enzymes to polypeptide was 1:80. 
prompted us to reinvestigate this problem by sub- 
mitting a preparation of C-I polypeptide to a systema- 
tic, quantitative study by both enzymatic digestion 
with carboxypeptidases A and B and by hydrazinolysis. 
Since Brown et al. [4] observed no release of amino 
acids by carboxypeptidase A or B at pH 8.5, the 
digestion of C-I was first performed at pH 5.8 and 37” 
[ 131 . The results of this time study (fig. 2) showed 
that the initial release of serine was 1.5-2 times 
greater than those of threonine, alanine and leucine. 
However, an almost identical result was obtained by 
digestion of C-I polypeptide with a mixture of car- 
boxypeptidases A and B at pH 8.5 and 37” (fig. 3). 
The alkaline pH had a slight influence on the overall 
rate of reaction rather than on the sequence of liber- 
ated amino acids. The amount of serine increased 
linearly with time and there was no leveling-off in the 
amount of this ammo acid after 24 hr. Due to a small 
quantity of available polypeptide preparation, longer 
digestion times were not investigated. To verify the 
results of enzymatic cleavage, the C-l polypeptide was 
submitted to hydrazinolysis at 3 different reaction 
times (lo,50 and 90 hr). In each instance, serine was 
identified by the amino acid analyzer as the only 
major acid (table 1); the optimal recovery of serine 
(52.3% of the theoretical value based on the molecular 
weight of 7000 [6] for C-I polypeptide) was achieved 
after 90 hr of hydrazinolysis. We concluded from these 
Table 1 
The release of amino acids from C-I polypeptide by hydrazin- 
olysis. 
Amino acids released 
~moles/lO’ mg of polypeptide 
10 hr 50hr 90 hr 
-- 
Serine 
Glycine 
Alanine 
3.5 5.0 7.5 
1.2 0.6 1.9 
0.70 0.4 1.1 
- 
studies that serine is the C-terminal amino acid of C-I 
polypeptide . 
Although it is difficult to explain the discrepancy 
between results presented in this study and those in 
the literature [4,6], the reported failure to observe 
a release of amino acids by enzymatic digestion could 
have been caused by either the conformational state 
of the C-I polypeptide, its poor solubility, or metho- 
dological differences. One should not overlook the 
enormous methodological difficulties in securing a 
quantity of C-I polypeptide sufficient for systematic 
time studies, and the possible lack of an adequate 
amount of this polypeptide in the original study [4] 
may have been an additional reason for failure to 
recognize serine as the C-terminal amino acid. Al- 
though one would expect the presence of C-I poly- 
peptide in the Sf 20-100 lipoproteins, Shore and 
Shore [ 141 reported that hydrazinolysis of the corre- 
sponding protein moiety failed to reveal valine as one 
of the C-terminal amino acids. 
3.3. N-terminal amino acid 
In agreement with the previously published reports 
[4,6] , results of a qualitative N-terminal amino acid 
analysis of C-I polypeptide by dansylation method 
confirmed threonine as the only N-terminus. 
Detection of serine as the C-terminal amino acid of 
C-I polypeptide may necessitate a reassessment of the 
C-terminal amino acid of apolipoprotein B (ApoB), the 
major protein moiety of very low- as well as low- 
density lipoproteins. Several years ago, Shore reported 
[ 151 that hydrazinolysis of low density lipoproteins 
with S, 7.9 and 7 .l yielded serine (2.2-2.5 bmoles/ 
lo3 mg protein), alanine (1.3-l .5 ~moles/103 mg 
protein), glycine (1.0-l .3 /.rmoles/103 mg protein) 
and threonine. This result has been interpreted as 
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evidence that serine is the C-terminus of ApoB which 
has been referred to as “R-Se? [ 16, 171. However, 
serine has not yet been confirmed as the C-terminal 
amino acid of ApoB. Moreover, Shore and Shore in- 
dicated in a recent report [ 141 that hydrazinolysis of 
a low-density lipoprotein with S, 4-8 performed with 
Amberlite CG50 resin as catalyst for 40 or 60 hr at 
80” did not yield serine. Since recent immunochemi- 
cal studies have revealed the presence of LP-C in the 
LDL subfractions [ 121, the small amount of detect- 
able serine by hydrazinolysis of LDL preparations may 
stem from and indicate the presence of C-I polypep- 
tide rather than apolipoprotein B. 
The finding of serine as the C-terminal amino acid 
of C-I polypeptide is significant not only because it 
raises the question of the C-terminus of ApoB, but 
also because it renders untenable the prevailing prac- 
tice of identifying the apolipoproteins or polypeptides 
by their terminal amino acids. It has been shown 
recently that glutamine is the C-terminal amino acid 
of both ApoA polypeptides [ 1 l] . The possible exis- 
tence of serine as the C-terminus of both ApoB and 
C-I polypeptide represents an additional argument 
supporting the recently proposed nomenclature [8, 
181 which is based on letters and numerals as codes 
for apolipoproteins and their constitutive polypep- 
tides. According to this proposal, the polypeptides of 
ApoA are called A-I (C-glutamine-N-aspartic acid) and 
A-II (C-glutamine-N-blocked), and the polypeptides 
of ApoC are designated as C-I (C-serine-N-threonine), 
C-II (C-glutamic acid-N-threonine) and C-III (C-alanine- 
N-serine). The polymorphic forms of C-III are identi- 
fied by arabic numerals such as C-III-O (absence of 
sialic acid), C-III-1 (one mole of sialic acid), C-III-2 
(two moles of sialic acid), etc. If necessary, the same 
coding system can be applied to the polymorphic forms 
of ApoA polypeptides. In absence of unequivocal 
evidence for the presence of non-identical polypeptides, 
the protein moiety of major low-density lipoprotein 
is simply called ApoB. 
Acknowledgements 
This study was supported in part by Grants HE-7005 
and HE-622 1 from the U.S. Public Health Service, and 
by the Oklahoma Heart Association. 
We thank Mrs. Carolyn Linhardt for her assistance 
with the preparation of polypeptides and Mrs. M. 
Farmer for her help in the preparation of the manu- 
script. 
References 
I11 
121 
131 
141 
I51 
161 
[71 
[Sl 
[91 
[lOI 
ill1 
[=I 
1131 
iI71 
[ISI 
A. Gustafson, P. Ataupovic and R.H. Furman, Biochim. 
Biophys. Acta 84 (1964) 767. 
P. Alaupovic, R.H. Furman, W.H. Falor, M.L. Sullivan, 
S.L. Walraven and AC. Olson,Ann. N.Y. Acad. Sci. 149 
(1968) 791. 
P. Alaupovic, G. Kostner, D.M. Lee, W.J. McConathy and 
H.N. Magnani, Exposes Ann. Biochem. Med. 31 (1971) 
in press. 
W.V. Brown, R.I. Levy and D.S. Fredrickson, J. Biol. 
Chem. 244 (1969) 5687. 
W.V. Brown, R.I. Levy and D.S. Fredrickson, Biochim. 
Biophys. Acta 280 (1970) 573. 
W.V. Brown, R.I. Levy and D.S. Fredrickson, J. Biol. 
Chem. 245 (1970) 6588. 
P. Alaupovic, D. Seidel, W.J. McConathy and R.H. Fur- 
man, FEBS Letters4 (1969) 113. 
W.J. McConathy, Dissertation, University of Oklahoma, 
Oklahoma City, 1971. 
G. Kostner and P. Alaupovic, Abstracts of papers, XIX 
Annual Colloquium on Protides of Biological Fluids, 
Brugge, Belgium (1971) p. 82. 
D. Seidel, P. Alaupovic, R.H. Furman and W.J. McCon- 
athy, J. Clin. Invest. 49 (1970) 2396. 
G. Kostner and P. Alaupovic, FEBS Letters 15 (197 1) 
320. 
D.M. Lee and P. Alaupovic, Biochemistry 9 (1970) 2244. 
K. Titani, K. Narita and K. Okunuki, J. Biochem. 
(Tokyo) 51 (1962) 350. 
B. Shore and V. Shore, Biochemistry 8 (1969) 45 10. 
B. Shore, Arch. Biochem. Biophys. 71 (1958) 1. 
D.S. Fredrickson, Proc. Natl. Acad. Sci. U.S. 64 (1969) 
1138. 
A.M. Gotto, R.I. Levy, K. John and D.S. Fredrickson, 
New Engl. J. Med. 284 (1971) 813. 
P. Alaupovic, Proceedings of the XIX Annual Colloquium 
on the Protides of Biological Fluids, Brugge, Belgium, 
197 1, Pergamon Press, in press. 
326 
